Literature DB >> 12783324

Epidermal growth factor receptor is a marker for syncytiotrophoblastic cells in testicular germ cell tumors.

Lukas Hechelhammer1, Stephan Störkel, Bernhard Odermatt, Philipp U Heitz, Wolfram Jochum.   

Abstract

The epidermal growth factor receptor (EGFR) has been implicated in the pathogenesis, therapy and prognosis of various tumor types. The aim of this study was to investigate EGFR expression in a large series of testicular germ cell tumors (TGCTs). A total of 88 TGCTs (37 of pure type and 51 of mixed type) comprising a total of 44 seminoma, 49 embryonal carcinoma, 32 yolk sac tumor, 28 teratoma and 7 choriocarcinoma components were immunostained for EGFR. EGFR reactivity was observed in the stromal cells of embryonal carcinoma (29%) and in epithelial compartments of teratoma (71%). In addition, EGFR staining was consistently detected in syncytiotrophoblastic cells of choriocarcinoma, seminoma, embryonal carcinoma and yolk sac tumor components. EGFR staining, similar to beta-human chorionic gonadotropin (HCG) immunohistochemistry, was efficiently able to identify syncytiotrophoblastic cells in TGCTs. This study shows that EGFR is expressed in a subset of testicular germ cell tumors and suggests that EGFR may be a useful marker for syncytiotrophoblastic cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783324     DOI: 10.1007/s00428-003-0835-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  24 in total

1.  Intermediate trophoblast in germ cell neoplasms.

Authors:  J C Manivel; G Niehans; M R Wick; L P Dehner
Journal:  Am J Surg Pathol       Date:  1987-09       Impact factor: 6.394

2.  Cytologic localization of epidermal growth factor and its receptor in developing human placenta varies over the course of pregnancy.

Authors:  C A Ladines-Llave; T Maruo; A S Manalo; M Mochizuki
Journal:  Am J Obstet Gynecol       Date:  1991-11       Impact factor: 8.661

3.  Localization of the cellular expression of inhibin in trophoblastic tissue.

Authors:  W G McCluggage; P Ashe; H McBride; P Maxwell; J M Sloan
Journal:  Histopathology       Date:  1998-03       Impact factor: 5.087

Review 4.  Testicular germ-cell cancer.

Authors:  G J Bosl; R J Motzer
Journal:  N Engl J Med       Date:  1997-07-24       Impact factor: 91.245

5.  Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors.

Authors:  M Moroni; S Veronese; R Schiavo; O Carminati; B S Sorensen; M Gambacorta; S Siena
Journal:  Clin Cancer Res       Date:  2001-09       Impact factor: 12.531

Review 6.  EGFR and cancer prognosis.

Authors:  R I Nicholson; J M Gee; M E Harper
Journal:  Eur J Cancer       Date:  2001-09       Impact factor: 9.162

7.  Decreased expression of epidermal growth factor and its receptor in the malignant transformation of trophoblasts.

Authors:  C A Ladines-Llave; T Maruo; A M Manalo; M Mochizuki
Journal:  Cancer       Date:  1993-06-15       Impact factor: 6.860

8.  Absence of c-KIT and members of the epidermal growth factor receptor family in refractory germ cell cancer.

Authors:  C Kollmannsberger; F Mayer; H Pressler; S Koch; L Kanz; J W Oosterhuis; L H J Looijenga; C Bokemeyer
Journal:  Cancer       Date:  2002-07-15       Impact factor: 6.860

9.  Prognostic factors in testicular germ cell tumours. Experiences from 1058 consecutive cases.

Authors:  M Vaeth; H P Schultz; H Von Der Maase; S A Engelholm; G Krag Jacobsen; B Nørgaard-Pedersen
Journal:  Acta Radiol Oncol       Date:  1984

10.  The significance of giant cells in human testicular seminomas. A clinico-pathological study.

Authors:  A R von Hochstetter; C Sigg; P Saremaslani; C Hedinger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985
View more
  5 in total

1.  Expression of EGFR, HER-2/neu and KIT in germ cell tumours.

Authors:  Ignacio Durán; Adelaida García-Velasco; Claudio Ballestín; Elena García; Francisco Martínez-Tello; Gregory R Pond; Rocío García-Carbonero; Hernán Cortés-Funés; Luis Paz-Ares
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

2.  Oncofetal protein glypican-3 in testicular germ-cell tumor.

Authors:  Satoshi Ota; Michiyo Hishinuma; Naoko Yamauchi; Akiteru Goto; Teppei Morikawa; Tetsuya Fujimura; Tadaichi Kitamura; Tatsuhiko Kodama; Hiroyuki Aburatani; Masashi Fukayama
Journal:  Virchows Arch       Date:  2006-08-04       Impact factor: 4.064

3.  An autopsy case of primary mixed choriocarcinoma and mature teratoma located in the thymic region associated with elevated human chorionic gonadotropin levels and characteristic testicular changes.

Authors:  Takashi Yuri; Naoto Shimano; Yasuhiro Ohashi; Katsuaki Miki; Reiko Tsukamoto; Airo Tsubura
Journal:  Med Mol Morphol       Date:  2006-03       Impact factor: 2.070

4.  Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.

Authors:  Miguel F Sanmamed; E Esteban; E Uriol; R Zarate; M Capelan; C Muriel; G Crespo; J P Berros; P Pardo-Coto; Q Perez; C Alvarez-Fernández; P Jiménez Fonseca; M Luque; A Astudillo
Journal:  J Transl Med       Date:  2017-03-20       Impact factor: 5.531

5.  IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.

Authors:  Joanna Selfe; Neil C Goddard; Alan McIntyre; Kathryn R Taylor; Jane Renshaw; Sergey D Popov; Khin Thway; Brenda Summersgill; Robert A Huddart; Duncan C Gilbert; Janet M Shipley
Journal:  J Pathol       Date:  2018-01-10       Impact factor: 7.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.